Medical Devices Today

Abbott Reports Two-Year Durability of MitraClip Mitral Valve Repair

 

Medtronic, Abbott Heart Stents Similarly Safe, Effective in Trial

Medtronic Increasingly Dependent on Foreign Markets for Device Sales

Medtronic Grabs Defib Market Lead As Boston Sci Device Pulled

Boston Sci Cleared By U.S., Europe to Market New Balloon Catheter

J&J’s Ethicon Faces Re-Inspection after Inadequate Response, FDA Says

Alcon, Advanced Medical Optics, Kinetic Defy Device-Sales Downturn

Boston Sci, Siemens, Philips Collaborate To Merge Ultrasound, X-Ray

Medtronic, Israel’s BioControl Said in Deal That Could Mean Acquisition

GE Spends $700 Million in First Year of Six-Year Health-Product Plan

Boston Sci’s Suspended Heart Products Return to U.S. Market

Covidien Patent Win against AMR Upheld By Federal Court Judge

Stryker Gets FDA Approval To Resume Device-Making In Ireland, U.S.

St. Jude Buys LightLab, Optical Tomography Work for $90 Million

Stryker Absolved Of Alabama Trident Hip-Implant Damage Claim

 

Bioactive Technologies for Bone Replacement

Article preview from Medtech Insight- April, 2010

The global market for orthobiologics, comprised primarily of bone replacement materials, reached almost $2 billion in 2009 and is growing at an overall rate of 7%. Medtronic leads in bone replacement with a 45% market share, but overall growth in orthobiologics may come from emerging segments, particular synthetic and stem-cell based technologies.

Medtech Venture Investing 2010: Do the Right Thing

Article preview from Start Up - May, 2010

In March 2010, Elsevier Business Intelligence convened a panel of venture capitalists and CEOs of devicestart-ups to discuss the climate for early and late stage funding. Their conclusion: there is money out there, if companies do the right things.

Cappella: Can a New Twist On An Old Idea Solve the Bifurcation Challenge?

Article preview from IN VIVO-  May, 2010

Device companies large and small have failed repeatedly in efforts to address bifurcations, which remain one of the largest unmet opportunities in cardiology. Cappella thinks it can solve the problem with a device that's a new version of an old idea, reversing current protocol to treat the side branch first.

FDA Worried That Class I Recall Jump Reflects Industry Rush To Market

Article preview from "The Silver Sheet"- May 24, 2010

A recent spike in Class I medical device recalls has led FDA to question whether manufacturers are sacrificing quality to rush products to market.

"We're concerned because we have seen a substantial increase in the number of recalls over the last few years," Steve Silverman, senior advisor to the CDRH director, said May 5 at the MedCon medical device conference in Cincinnati.

FDA Worried That Class I Recall Jump Reflects Industry Rush To Market

Article preview from "The Gray Sheet"- May 24, 2010

A recent spike in Class I medical device recalls has led FDA to question whether manufacturers are sacrificing quality to rush products to market.

FDA Unveils 21 Policy Changes To Increase Transparency With Public

Article preview from "The Gray Sheet"-  May 24, 2010

FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency.

SSI: Revolutionizing Breast Cancer Detection, but Slowly

Article preview from IN VIVO-  April, 2010

Building off conventional ultrasound technology, France's SSI hopes to change the way breast cancer detection is done, reducing the number of unnecessary biopsies by employing elastography to register the stiffness of breast tissue. But as the company seeks to challenge a 3000 year old, low tech approach--manual palpation--company officials are proceeding slowly and are cautious about the claims they make for their technology's innovativeness.

Insulin Device Companies' New Mantra: Real Simple

Article preview from Start Up - April, 2010

Companies developing devices for diabetes have to ask a question that companies in other medical device fields don't: what about the users, the people with diabetes? How will they use the device?

Device-Based Stroke Intervention: An Interview with Adnan Siddiqui

Article preview from Medtech Insight- April, 2010

Medtech Insight interviews Adnan Siddiqui, MD, PhD, assistant professor of neurosurgery and radiology at the State University of New York, Buffalo, a pioneer in the use of interventional technology for acute ischemic stroke. Siddiqui offers his perspective on the current state of endovascular devices for AIS, the unique challenges faced by physicians in this field, and the factors driving interest in stent-based technologies.